Jan 31 (Reuters) - Maze Therapeutics (MAZE.O), opens new tab became the latest drug developer to list in New York on Friday, with its shares rising nearly 1% in their debut, giving the company a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback